Short answer
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA. It belongs to a family of mitochondrial-derived peptides (MDPs) and is studied in metabolic, exercise and mitochondrial research models. It is sold as a lyophilized research powder for laboratory use only.
What is MOTS-c?
MOTS-c was first described in a 2015 Cell Metabolism study that identified a short open reading frame inside the mitochondrial 12S rRNA gene [1]. In other words, a small peptide is encoded not by the nuclear genome but by the mitochondria themselves. The peptide is 16 amino acids long and is highly conserved across species.
Its discovery opened a research area asking how mitochondria communicate with the rest of the cell through small peptides [1][3]. MOTS-c is one of a small group of mitochondrial-derived peptides (MDPs) that includes humanin, and a 2016 review in Free Radical Biology and Medicine frames these peptides as a challenge to the older assumption that the mitochondrial genome encodes only the machinery of energy production [3].
What does the name stand for?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. The name is descriptive: the peptide is encoded by a reading frame found within the mitochondrial 12S ribosomal RNA gene, and the "type-c" distinguishes it from other reading frames in the same region. Researchers who work with the molecule usually refer to it simply as MOTS-c.
Conservation and cellular localization
Two features of MOTS-c shape how it is studied. First, the peptide is highly conserved across species, which means findings in mice and cell models are considered informative for understanding its basic biology. Second, MOTS-c is normally produced inside mitochondria, but it is reported to act beyond the mitochondrion - it can be detected in the circulation and can enter other cellular compartments, including the nucleus under certain conditions [4]. This behavior is what makes it a signaling peptide rather than just another mitochondrial structural component.
The localization point is worth emphasizing because it defines the experimental approach. Researchers who study MOTS-c often measure both where the peptide goes and what it changes: nuclear localization under metabolic stress, effects on gene expression, and downstream metabolic readouts [4]. Studies that track the peptide's movement alongside its functional effects provide the richest picture of how a mitochondrial peptide signals to the rest of the cell.
The AMPK signaling connection
The mechanistic story of MOTS-c centers on cellular energy sensing. A key reported pathway is the folate-AICAR-AMPK axis. In this model, MOTS-c regulates the folate-methionine cycle, leading to the accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), which in turn activates AMPK, a master sensor of cellular energy status [4]. AMPK activation is a central theme in metabolic research because it coordinates glucose handling, lipid metabolism and mitochondrial function.
A second layer involves nuclear signaling. Under metabolic stress such as glucose restriction or oxidative stress, MOTS-c can translocate to the nucleus, where it has been reported to interact with transcription factors to regulate adaptive gene expression [4]. This mitochondrial-to-nuclear signaling is one of the most interesting aspects of the MDP field: a peptide made by the mitochondria influencing the nucleus, effectively acting as a mitochondrial hormone.
What researchers study
MOTS-c appears in the literature across several themes:
The 2015 Cell Metabolism paper is the founding study: it described the discovery of MOTS-c and reported that the peptide promotes metabolic homeostasis and reduces obesity and insulin resistance in mice [1]. The exercise angle was strengthened by the 2021 Nature Communications study, which reported that MOTS-c acts as an exercise-induced regulator of age-dependent physical decline and muscle homeostasis in mice [2]. A 2023 review in the Journal of Translational Medicine provides a broad synthesis of the stress, metabolism and aging literature on MOTS-c [4].
A related thread concerns age-dependent changes in MOTS-c levels themselves. Several studies report that circulating MOTS-c declines with age, and that the peptide's effects in aged animals differ from its effects in younger ones - for example, restoring physical performance in aging mice [2]. This age-dependence is a common feature of mitochondrial-derived peptides and is one reason they are discussed in the longevity research space. For a laboratory, it is a reminder that results can depend heavily on the age and metabolic state of the model system used.
The exercise angle in more depth
The exercise connection is one of the most distinctive features of the MOTS-c literature. The 2021 Nature Communications study reported that exercise increases MOTS-c levels and that the peptide influences physical performance and the maintenance of muscle homeostasis in aging mice [2]. This places MOTS-c within a broader field that asks how physical activity signals through mitochondrial peptides, and it is why the molecule is often discussed in exercise and metabolic adaptation research rather than in the tissue-repair space occupied by peptides like BPC-157 or TB-500.
Mechanistically, the exercise and metabolic themes converge on the same sensor. Reported effects connect MOTS-c to AMPK activation, a pathway that responds to cellular energy status and coordinates metabolic adaptation [4]. This is a different research tradition from receptor-driven pharmacology: MOTS-c is studied as a signaling peptide from the mitochondria that influences how cells sense and respond to metabolic demand.
Reading the MOTS-c evidence critically
As with other research peptides, the MOTS-c evidence base deserves a careful read. The founding observations - that the peptide is encoded in mitochondrial DNA and influences metabolic homeostasis in mice - are well established in the primary literature [1]. But the field is relatively young, and much of the human-relevant data comes from observational work linking circulating MOTS-c levels to physiological states rather than from controlled experiments with the synthetic peptide.
The distinction matters for laboratory use. Studies that administer the synthetic peptide to cells or animals are directly relevant to a lab working with research-grade MOTS-c. Studies that only measure endogenous MOTS-c levels describe a different relationship. When designing an experiment, it helps to match the design to the type of evidence being sought, and to report the peptide source and purity transparently so results can be compared across labs.
Key facts at a glance
| Property | Detail |
|---|---|
| Type | Mitochondrial-derived peptide |
| Length | 16 amino acids |
| Source | Encoded in mitochondrial 12S rRNA |
| First described | 2015, Lee et al., Cell Metabolism |
| Reported mechanism | Folate-AICAR-AMPK axis, nuclear translocation |
| Research themes | Metabolism, exercise, mitochondrial signaling |
| Typical form | Lyophilized powder |
| Purity expectation | 99%+ by HPLC |
MOTS-c in context: the mitochondrial peptide family
MOTS-c is often discussed together with humanin, the other well-known mitochondrial-derived peptide. Where humanin research has focused heavily on cellular stress protection and longevity-related models, MOTS-c research has focused more on metabolic regulation and physical performance [3]. For a researcher choosing between them, the decision usually comes down to the experimental question: metabolic and exercise adaptation models lean toward MOTS-c, while cellular stress and survival models lean toward humanin. The two peptides belong to the same broad family but are studied in different contexts.
Experimental considerations
When a protocol uses MOTS-c, the metabolic readouts drive the design. Common end-points include glucose handling in cell culture, insulin signaling markers, and AMPK activation status, all of which pair naturally with the folate-AICAR-AMPK mechanism described above [4]. For exercise and aging questions, researchers often use animal models and measure physical performance alongside muscle-related outcomes, as in the 2021 study [2].
Practical details mirror other research peptides: run a concentration series where the effect is expected to be concentration-dependent, include vehicle controls, and confirm the salt form on the COA. Because MOTS-c is a short, unmodified peptide, identity by mass spectrometry is straightforward, and a batch-specific COA with an HPLC chromatogram is the baseline quality expectation for research-grade material.
Storage and handling
MOTS-c is supplied as a lyophilized powder and follows standard peptide handling:
What to check before buying MOTS-c
You can review MOTS-C product options and verify batch documents on the quality portal.
FAQ
What is MOTS-c?
A 16-amino-acid peptide encoded by mitochondrial DNA, part of the mitochondrial-derived peptide family.
What does MOTS-c stand for?
Mitochondrial open reading frame of the 12S rRNA type-c.
How is MOTS-c studied?
In cell and animal models of metabolism, exercise adaptation, insulin signaling and mitochondrial function.
Is MOTS-c for human use?
No, it is a lyophilized research powder for laboratory research only.